Literature DB >> 10928467

The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.

F Kamali1, C Edwards, T J Butler, H A Wynne.   

Abstract

The contribution of (R)- and (S)-warfarin enantiomers, vitamin K and vitamin K epoxide and patient factors to inter-individual variability in daily warfarin requirements were examined in a group of 73 patients. Simple correlation analysis showed a significant positive relationship between INR values and plasma (S)-warfarin concentrations (r = 0.25; p = 0.038). Multivariate analysis for relationships with INR demonstrated a highly significant positive relationship between INR and (S)-warfarin (p = 0.004) and plasma vitamin K epoxide concentrations (p = 0.028), and a significant negative relationship between INR and plasma vitamin K concentrations (p = 0.034). Twenty five percent of variation in INR could be explained by these variables (adjusted R2 = 0.25). Correlation analysis of data showed that warfarin dosage was significantly and negatively correlated with patient age (r = -0.42; p <0.0001). Patient age accounted for 25% of variation in warfarin dosage requirements (R2 = 0.25). The combined effects of age and vitamin K appear to account for much of the inter-individual variability in warfarin dosage requirements.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928467

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  The future prospects of pharmacogenetics in oral anticoagulation therapy.

Authors:  Farhad Kamali; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

2.  Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.

Authors:  Russell A Wilke; Richard L Berg; Humberto J Vidaillet; Michael D Caldwell; James K Burmester; Michael A Hillman
Journal:  Clin Med Res       Date:  2005-11

3.  High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.

Authors:  Y-E Kim; H I Woo; Y K On; J S Kim; S-Y Lee
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

4.  Factors affecting the maintenance stable warfarin dosage in Hong Kong Chinese patients.

Authors:  Vivian W Y Lee; Joyce H S You; Kenneth K C Lee; T S Chau; Mary M Y Waye; Gregory Cheng
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

5.  Relationship between diet and anticoagulant response to warfarin: a factor analysis.

Authors:  Silvia Maria Custódio das Dôres; Sarah L Booth; Ligia Araújo Martini; Ligia Aújo Martini; Victor Hugo de Carvalho Gouvêa; Carlos Roberto Padovani; Francisco Humberto de Abreu Maffei; Alvaro Oscar Campana; Sérgio Alberto Rupp de Paiva
Journal:  Eur J Nutr       Date:  2007-03-13       Impact factor: 5.614

6.  A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.

Authors:  Jinxing Chen; Liying Shao; Ling Gong; Fang Luo; Jin'e Wang; Yi Shi; Yu Tan; Qianlong Chen; Yu Zhang; Rutai Hui; Yibo Wang
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.